Calcium phosphate-based composite nanoparticles in bioimaging and therapeutic delivery applications

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 4, Issue 1, 2012, Pages 96-112

  Tabaković, Amra ^a   Kester, Mark ^b   Adair, James H ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIO-IMAGING; BIOMEDICAL APPLICATIONS; CALCIUM PHOSPHATE MATERIALS; COMPOSITE NANOPARTICLES; IN-VITRO; NANOMATERIAL; PH-DEPENDENT; PHYSICOCHEMICAL PROPERTY; SIGNIFICANT IMPACTS; THERAPEUTIC DELIVERY; THERAPEUTIC DRUG DELIVERY;

CALCIUM; COMPOSITE MATERIALS; DRUG DELIVERY; MEDICAL APPLICATIONS; NANOPARTICLES; OLIGONUCLEOTIDES;

CALCIUM PHOSPHATE;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CALCIUM PHOSPHATE; CALCIUM PHOSPHOSILICATE; CARBOXYMETHYLCELLULOSE; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; DENDRIMER; DNA; DOCETAXEL; DYE; EUDRAGIT; FLUORESCEIN; HYDROXYAPATITE; INDOCYANINE GREEN; INSULIN; LANTHANIDE; LIPOSOME; MACROGOL; METAL; METHOTREXATE; NANOPARTICLE; OLEIC ACID; OLIGONUCLEOTIDE; PHOSPHATIDYLCHOLINE; POLYMER; RHODAMINE; SILICATE; SILICON DIOXIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BIOIMAGING; COLLOID; COLON CANCER; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; GENE DELIVERY SYSTEM; HUMAN; IMAGING; MACROPHAGE; MICELLE; MONOCYTE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; SURFACE PROPERTY;

ANIMALS; CALCIUM PHOSPHATES; DRUG DELIVERY SYSTEMS; HUMANS; MICE; MOLECULAR IMAGING; NANOCOMPOSITES;

EID: 83655211712     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.163     Document Type: Article

References (56)

1. Yih TC, Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 2006, 97:1184-1190.
2. Adair JH, Parette MP, Altinoǧlu EI, Kester M. Nanoparticulate alternatives for drug delivery. ACS Nano 2010, 4:4967-4970.
3. Altinoǧlu EI, Russin TJ, Kaiser JM, Barth BM, Eklund PC, Kester M, Adair JH. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano 2008, 2:2075-2084.
4. Morgan TT, Muddana HS, Altinoǧlu EI, Rouse SM, Tabaković A, Tabouillot T, Russin TJ, Shanmugavelandy SS, Butler PJ, Eklund PC, et al. Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery. Nano Lett 2008, 8:4108-4115.
5. Kester M, Heakal Y, Fox T, Sharma A, Robertson GP, Morgan TT, Altinoĝlu EI, Tabaković A, Parette MR, Rouse SM, et al. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett 2008, 8:4116-4121.
6. Barth BM, Sharma R, Altinoǧlu EI, Morgan TT, Shanmugavelandy SS, Kaiser JM, McGovern C, Matters GL, Smith JP, Kester M, et al. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo. ACS Nano 2010, 4:1279-1287.
7. Mondejar SP, Kovtun A, Epple M. Lanthanide-doped calcium phosphate nanoparticles with high internal crystallinity and with a shell of DNA as fluorescent probes in cell experiments. J Mater Chem 2007, 17:4153-4159.
8. Al-Kattan A, Dufour P, Dexpert-Ghys J, Drouet C. Preparation and physicochemical characteristics of luminescent apatite-based colloids. J Phys Chem C 2010, 114:2918-2924.
9. Neumeier M, Hails LA, Davis SA, Mann S, Epple M. Synthesis of fluorescent core-shell hydroxyapatite nanoparticles. J Mater Chem 2011, 21:1250-1254.
10. Chen YC, Ostafin A, Mizukami H. Synthesis and characterization of pH sensitive carboxySNARF-1 nanoreactors. Nanotechnology 2010, 21:215503.
11. Li J, Chen YC, Tseng YC, Mozumdar S, Huang L. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J Control Release 2010, 142:416-421.
12. Graham FL, Van Der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52:456-473.
13. Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of nanoparticles and drugs to tumors. J Cell Biol 2010, 188:759-768.
14. Fang C, Bhattarai N, Sun C, Zhang M. Functionalized nanoparticles with long-term stability in biological media. Small 2009, 5:1637-1641.
15. Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, Ruiz L, Gonzalez-Calbet JM, Vallet-Regi M, Zellner R, Köller M, et al. The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles. J Mater Chem 2010, 20:512-518.
16. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 2008, 101:239-253.
17. Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg Med Chem 2009, 17:2950-2962.
18. Morgan TT, Goff TM, Adair JH. The colloidal stability of fluorescent calcium phosphosilicate nanoparticles: the effects of evaporation and redispersion on particle size distribution. Nanoscale 2011, 3:2044-2053.
19. Gao W, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Mol Pharm 2010, 7:1913-1920.
20. Chander S, Fuerstenau DW. On the dissolution and interfacial properties of hydroxyapatite. Colloids Surf 1982, 4:101-120.
21. Tung MS. Calcium phosphates: structure, composition, solubility, and stability. In: Amjad Z, ed. Calcium Phosphates in Biological and Industrial Systems. Boston: Kluwer Academic Publishers; 1998, 1-19.
22. Mellman I, Fuchs R, Helenius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 1986, 55:663-700.
23. Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue. Cancer Res 1996, 56: 1194-1198.
24. Vijayaraghavalu S, Raghavan D, Labhasetwar V. Nanoparticles for delivery of chemotherapeutic agents to tumors. Curr Opin Invest Drugs 2007, 8:477-484.
25. Oyane A, Kim H, Furuya T, Kobuko T, Miyazaki T, Nakamura T. Preparation and assessment of revised simulated body fluids. J Biomed Mater Res A 2003, 65A:188-195.
26. Cerella C, Diederich M, Ghibelli L. The dual role of calcium as messenger and stressor in cell damage, death and survival. Int J Cell Biol 2010, 2010:1-14.
27. Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, Neumann M, Shanahan CM, Proudfoot D. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells A potential mechanism in atherosclerotic plaque destabilization. Circ Res 2008, 103:e28-e34.
28. Liu ZS, Tang SL, Ai ZL. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells. World J Gastroenterol 2003, 9:1968-1971.
29. Motskin M, Wright D, Muller K, Kyle N, Gard T, Porter AE, Skepper JN. Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability. Biomaterials 2009, 30:3307-3317.
30. Sokolova V, Kovtun A, Prymak O, Meyer-Zaika W, Kubareva EA, Romanova EA, Oretskaya TS, Heumann R, Epple M. Functionalisation of calcium phosphate nanoparticles by oligonucleotides and their application for gene silencing. J Mater Chem 2007, 17:721-727.
31. Sokolova V, Radtke I, Heumann R, Epple M. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials 2006, 27:3147-3153.
32. Sokolova V, Knuschke T, Kovtun A, Buer J, Epple M, Westendorf AM. The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation. Biomaterials 2010, 31:5627-5633.
33. Muddana HS, Morgan TT, Adair JH, Butler PJ. Photophysics of Cy3-encapsulated calcium phosphate nanoparticles. Nano Lett 2009, 9:1559-1566.
34. Russin T, Altinoǧlu E, Adair J, Ecklund P. Measuring the fluorescent quantum efficiency of indocyanine green encapsulated in nanocomposite particulates. J Phys Condens Matter 2010, 22:334217.
35. Schwiertz J, Wiehe A, Gräfe S, Gitter B, Epple M. Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria. Biomaterials 2009, 30:3324-3331.
36. Klesing J, Wiehe A, Gitter B, Gräfe S, Epple M. Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy. J Mater Sci Mater Med 2010, 21:887-892.
37. Ramachandran R, Paul W, Sharma CP. Synthesis and characterization of pegylated calcium phosphate nanoparticles for oral insulin delivery. J Biomed Mater Res B Appl Biomater 2009, 88B:41-48.
38. Luo Y, Ling Y, Guo W, Pang J, Liu W, Fang Y, Wen X, Wei K, Gao X. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells. J Control Release 2010, 147:278-288.
39. Welzel T, Radtke I, Meyer-Zaika W, Heumann R, Epple M. Transfection of cells with custom-made calcium phosphate nanoparticles coated with DNA. J Mater Chem 2004, 14:2213-2217.
40. Mukesh U, Kulkarni V, Tushar R, Murthy RSR. Methotrexate loaded self stabilized calcium phosphate nanoparticles: a novel inorganic carrier for intracellular drug delivery. J Biomed Nanotech 2009, 5:99-105.
41. Bisht S, Bhakta G, Mitra S, Maitra A. pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery. Int J Pharm 2005, 288:157-168.
42. Serpe L. Conventional chemotherapeutic drug nanoparticles for cancer treatment. Nanomater Cancer Ther 2006, 6:1-30.
43. Barroug A, Kuhn LT, Gerstenfeld LC, Glimcher MJ. Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release. J Orth Res 2004, 22:703-708.
44. Pareta RA. Calcium phosphate nanoparticles: toxicology and lymph node targeting for cancer metastasis prevention. Saf Nanoparticles 2009, XII:189-208.
45. Zhang G, Liu T, Chen YH, Chen Y, Xu M, Peng J, Yu S, Yuan J, Zhang X. Tissue specific cytotoxicity of colon cancer cells mediated by nanoparticle-delivered suicide gene in vitro and in vivo. Clin Cancer Res 2009, 15:201-207.
46. Altinoǧlu E, Adair J. Near infrared imaging with nanoparticles. WIREs Nanomed Nanobiotechnol 2010, 2:461-477.
47. Kulkarni VI, Shenoy VS, Dodiya SS, Rajyaguru TH, Murthy RR. Role of calcium in gene delivery. Exp Opin Drug Del 2006, 3:235-245.
48. Sokolova V, Kovtun A, Heumann R, Epple M. Tracking the pathway of calcium phosphate/DNA nanoparticles during cell transfection by incorporation of red-fluorescing tetramethylrhodamine isothiocyanate-bovine serum albumin into these nanoparticles. J Biol Inorg Chem 2007, 12:174-179.
49. Olton D, Li J, Wilson ME, Rogers T, Close J, Huang L, Kumta PN, Sfeir C. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: Influence of the synthesis parameters on transfection efficiency. Biomaterials 2007, 28:1267-1279.
50. Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements as bone drug delivery systems: a review. J Control Release 2006, 113:102-110.
51. Verron E, Khairoun I, Guicheux J, Bouler J-M. Calcium phosphate biomaterials as bone drug delivery systems: a review. Drug Discovery Today 2010, 15:547-552.
52. Dorozhkin S. Bioceramics based on calcium orthophosphates (review). Glass Ceram 2007, 64:442-447.
53. Dorozhkin S. Calcium orthophosphate cements for biomedical application. J Mater Sci 2008, 43: 3028-3057.
54. Chu TC, He Q, Potter DE. Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent. J Ocul Pharmacol Ther 2002, 18:507-514.
55. Ryland L, Fox T, Liu X, Loughran T, Kester M. Dysregulation of sphingolipid metabolism in cancer. Cancer Biol Ther 2011, 11:138-149.
56. McNeil S. Nanoparticle therapeutics: a personal perspective. WIREs Nanomed Nanobiotechnol 2009, 1:264-271.